Other mutational signatures including SBS40, SBS5, ID9, ID1 and ID2 were not significantly enriched more in BRCA1/2-mutated cancers expressing wild-type POLQ than in other types of cancers (Supplementary Figure S3A and B). Here, POLQ is linked to cancer.